An underground market for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Treatment Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing market exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.
Some professionals said the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or prison.
Platform Response and Material Elimination
According to the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and investing in enhancing compliance measures.
Online Marketplace Activities
Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, positive reviews and step-by-step instructions for preparing or injecting at home.
After minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, messages show black plastic packages with postal service stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is valid, these digital products may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously seen individuals injured by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet approved … may expose patients to potentially significant medical dangers”.
